Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
24042 | 325 | 37.6 | 86% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
112 | 3 | CERVICAL CANCER//HUMAN PAPILLOMAVIRUS//GYNECOLOGIC ONCOLOGY | 70812 |
32 | 2 | HUMAN PAPILLOMAVIRUS//HPV//CERVICAL CANCER | 32910 |
24042 | 1 | FUSED TOES HOMOLOG//PAN RAS//A RADIATION DOSE OF 27 GY | 325 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | FUSED TOES HOMOLOG | authKW | 211396 | 1% | 75% | 3 |
2 | PAN RAS | authKW | 169115 | 1% | 60% | 3 |
3 | A RADIATION DOSE OF 27 GY | authKW | 93954 | 0% | 100% | 1 |
4 | ABERRANT IMMUNOREACTIVITY | authKW | 93954 | 0% | 100% | 1 |
5 | ADOPTIVE NK IMMUNOTHERAPY | authKW | 93954 | 0% | 100% | 1 |
6 | ADVANCED CANCER OF THE CERVIX | authKW | 93954 | 0% | 100% | 1 |
7 | AUMS MED | address | 93954 | 0% | 100% | 1 |
8 | BCL 2 ESPRESSION | authKW | 93954 | 0% | 100% | 1 |
9 | BIOL SCI ENGN CANC MINIST EDUC | address | 93954 | 0% | 100% | 1 |
10 | BIOLOGICAL PROGNOSTIC FACTOR | authKW | 93954 | 0% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 5623 | 67% | 0% | 218 |
2 | Obstetrics & Gynecology | 2987 | 29% | 0% | 95 |
3 | Pathology | 509 | 12% | 0% | 38 |
4 | Radiology, Nuclear Medicine & Medical Imaging | 29 | 5% | 0% | 16 |
5 | Reproductive Biology | 27 | 2% | 0% | 7 |
6 | Medicine, Research & Experimental | 18 | 4% | 0% | 13 |
7 | Medical Laboratory Technology | 11 | 1% | 0% | 4 |
8 | Cell Biology | 4 | 4% | 0% | 13 |
9 | Anatomy & Morphology | 3 | 1% | 0% | 2 |
10 | Biotechnology & Applied Microbiology | 1 | 2% | 0% | 8 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | AUMS MED | 93954 | 0% | 100% | 1 |
2 | BIOL SCI ENGN CANC MINIST EDUC | 93954 | 0% | 100% | 1 |
3 | GRP ONCOL GINECOL | 93954 | 0% | 100% | 1 |
4 | HEPATOBILIA | 93954 | 0% | 100% | 1 |
5 | HISTOCHEM ELE ON MICROSCOPY | 93954 | 0% | 100% | 1 |
6 | IAC TASK FORCE 5 | 93954 | 0% | 100% | 1 |
7 | IFR PHYSIOL PATHOPHYSIOL 2 | 93954 | 0% | 100% | 1 |
8 | JOHN VANE SCI GYNAECOL ONCOL | 93954 | 0% | 100% | 1 |
9 | LU683 | 93954 | 0% | 100% | 1 |
10 | LUDWIG BOLTZMANN CLIN EPXT ONCOL | 93954 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | GYNECOLOGIC ONCOLOGY | 11944 | 12% | 0% | 38 |
2 | EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY | 4617 | 4% | 0% | 12 |
3 | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 4125 | 4% | 0% | 14 |
4 | INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY | 2916 | 2% | 0% | 8 |
5 | CANCER DETECTION AND PREVENTION | 1477 | 2% | 0% | 5 |
6 | CANCER | 854 | 5% | 0% | 16 |
7 | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 767 | 4% | 0% | 12 |
8 | ANTICANCER RESEARCH | 692 | 4% | 0% | 12 |
9 | JOURNAL OF CLINICAL PATHOLOGY | 681 | 2% | 0% | 8 |
10 | AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY | 501 | 1% | 0% | 4 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | FUSED TOES HOMOLOG | 211396 | 1% | 75% | 3 | Search FUSED+TOES+HOMOLOG | Search FUSED+TOES+HOMOLOG |
2 | PAN RAS | 169115 | 1% | 60% | 3 | Search PAN+RAS | Search PAN+RAS |
3 | A RADIATION DOSE OF 27 GY | 93954 | 0% | 100% | 1 | Search A+RADIATION+DOSE+OF+27+GY | Search A+RADIATION+DOSE+OF+27+GY |
4 | ABERRANT IMMUNOREACTIVITY | 93954 | 0% | 100% | 1 | Search ABERRANT+IMMUNOREACTIVITY | Search ABERRANT+IMMUNOREACTIVITY |
5 | ADOPTIVE NK IMMUNOTHERAPY | 93954 | 0% | 100% | 1 | Search ADOPTIVE+NK+IMMUNOTHERAPY | Search ADOPTIVE+NK+IMMUNOTHERAPY |
6 | ADVANCED CANCER OF THE CERVIX | 93954 | 0% | 100% | 1 | Search ADVANCED+CANCER+OF+THE+CERVIX | Search ADVANCED+CANCER+OF+THE+CERVIX |
7 | BCL 2 ESPRESSION | 93954 | 0% | 100% | 1 | Search BCL+2+ESPRESSION | Search BCL+2+ESPRESSION |
8 | BIOLOGICAL PROGNOSTIC FACTOR | 93954 | 0% | 100% | 1 | Search BIOLOGICAL+PROGNOSTIC+FACTOR | Search BIOLOGICAL+PROGNOSTIC+FACTOR |
9 | C ERB B 2 HER2 | 93954 | 0% | 100% | 1 | Search C+ERB+B+2+HER2 | Search C+ERB+B+2+HER2 |
10 | C ERB B2 STATUS | 93954 | 0% | 100% | 1 | Search C+ERB+B2+STATUS | Search C+ERB+B2+STATUS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SOONTHORNTHUM, T , ARIAS-PULIDO, H , JOSTE, N , LOMO, L , MULLER, C , RUTLEDGE, T , VERSCHRAEGEN, C , (2011) EPIDERMAL GROWTH FACTOR RECEPTOR AS A BIOMARKER FOR CERVICAL CANCER.ANNALS OF ONCOLOGY. VOL. 22. ISSUE 10. P. 2166 -2178 | 39 | 41% | 42 |
2 | TIAN, WJ , HUANG, ML , QIN, QF , CHEN, Q , FANG, K , WANG, PL , (2016) PROGNOSTIC IMPACT OF EPIDERMAL GROWTH FACTOR RECEPTOR OVEREXPRESSION IN PATIENTS WITH CERVICAL CANCER: A META-ANALYSIS.PLOS ONE. VOL. 11. ISSUE 7. P. - | 27 | 57% | 0 |
3 | VOSMIK, M , LACO, J , SIRAK, I , BERANEK, M , HOVORKOVA, E , VOSMIKOVA, H , DRASTIKOVA, M , HODEK, M , ZOUL, Z , ODRAZKA, K , ET AL (2014) PROGNOSTIC SIGNIFICANCE OF HUMAN PAPILLOMAVIRUS (HPV) STATUS AND EXPRESSION OF SELECTED MARKERS (HER2/NEU, EGFR, VEGF, CD34, P63, P53 AND KI67/MIB-1) ON OUTCOME AFTER (CHEMO-) RADIOTHERAPY IN PATIENTS WITH SQUAMOUS CELL CARCINOMA OF UTERINE CERVIX.PATHOLOGY & ONCOLOGY RESEARCH. VOL. 20. ISSUE 1. P. 131-137 | 16 | 62% | 4 |
4 | YAMASHITA, H , MURAKAMI, N , ASARI, T , OKUMA, K , OHTOMO, K , NAKAGAWA, K , (2009) CORRELATION AMONG SIX BIOLOGIC FACTORS (P53, P21(WAF1), MIB-1, EGFR, HER2, AND BCL-2) AND CLINICAL OUTCOMES AFTER CURATIVE CHEMORADIATION THERAPY IN SQUAMOUS CELL CERVICAL CANCER.INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. VOL. 74. ISSUE 4. P. 1165-1172 | 20 | 49% | 18 |
5 | LU, X , FEKI, A , (2006) PHENOTYPIC FEATURES WITH P53 ALTERATIONS RELATED TO HUMAN PAPILLOMAVIRUS AND PROGNOSTIC EVALUATION IN CERVICAL CANCER.INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. VOL. 16. ISSUE 2. P. 708 -717 | 30 | 35% | 8 |
6 | CALIFANO, D , LOSITO, S , PISANO, C , SANTELLI, G , GREGGI, S , IODICE, F , DIVAGNO, G , SILVESTRO, G , TAMBARO, R , FORMATO, R , ET AL (2006) SIGNIFICANCE OF ERB-B2 IMMUNOREACTIVITY IN CERVICAL CANCER.FRONTIERS IN BIOSCIENCE-LANDMARK. VOL. 11. ISSUE . P. 2071-2076 | 15 | 68% | 2 |
7 | PEREZ-REGADERA, J , SANCHEZ-MUNOZ, A , DE-LA-CRUZ, J , BALLESTIN, C , LORA, D , GARCIA-MARTIN, R , MENDIOLA, C , ALONSO, L , ALBA, E , LANZOS, E , (2009) NEGATIVE PROGNOSTIC IMPACT OF THE COEXPRESSION OF EPIDERMAL GROWTH FACTOR RECEPTOR AND C-ERBB-2 IN LOCALLY ADVANCED CERVICAL CANCER.ONCOLOGY. VOL. 76. ISSUE 2. P. 133-141 | 19 | 44% | 15 |
8 | BARBU, I , CRAITOIU, S , SIMIONESCU, CE , DRAGNEI, AM , MARGARITESCU, C , (2013) CD105 MICROVESSELS DENSITY, VEGF, EGFR-1 AND C-ERBB-2 AND THEIR PROGNOSTIC CORRELATION IN DIFFERENT SUBTYPES OF CERVICAL ADENOCARCINOMA.ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY. VOL. 54. ISSUE 3. P. 519-530 | 26 | 28% | 6 |
9 | CONESA-ZAMORA, P , TORRES-MORENO, D , ISAAC, MA , PEREZ-GUILLERMO, M , (2013) GENE AMPLIFICATION AND IMMUNOHISTOCHEMICAL EXPRESSION OF ERBB2 AND EGFR IN CERVICAL CARCINOGENESIS. CORRELATION WITH CELL-CYCLE MARKERS AND HPV PRESENCE.EXPERIMENTAL AND MOLECULAR PATHOLOGY. VOL. 95. ISSUE 2. P. 151 -155 | 14 | 52% | 6 |
10 | OZALP, SS , YALCIN, OT , TANIR, HM , DUNDAR, E , YILDIRIM, S , (2002) BCL-2 EXPRESSION IN PREINVASIVE AND INVASIVE CERVICAL LESIONS.EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY. VOL. 23. ISSUE 5. P. 419-422 | 11 | 85% | 8 |
Classes with closest relation at Level 1 |